NCT07538076Not yet recruiting
Validation of Web-Based Star Cancellation and Line Bisection Tests in Hemiplegic Stroke
Development and Validity of Web Based Star Cancellation Test and Line Bisection Test in the Assessment of Visuospatial Neglect in Hemiplegic Stroke Patients
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate the clinical usability and diagnostic performance of newly developed web-based Star Cancellation and Line Bisection tests in assessing visuospatial neglect in hemiplegic stroke patients. It will also compare these digital tests with conventional paper-and-pencil assessments. The main questions it aims to answer are: Can the web-based Star Cancellation and Line Bisection tests accurately distinguish between stroke patients with and without visuospatial neglect? Do digital test parameters (such as completion time, search speed, and search patterns) provide additional clinical information beyond conventional test scores? Researchers will compare the results of the web-based tests with standard paper-and-pencil tests to evaluate their diagnostic accuracy and clinical validity. Participants will: Complete conventional paper-and-pencil Star Cancellation and Line Bisection tests Perform web-based (digital) versions of the same tests using a tablet and stylus Undergo routine clinical and cognitive assessments as part of standard care Provide demographic and clinical information
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 105 (estimated)
- First submitted
- 12 Apr 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 15 Oct 2026
- Lead sponsor
- Istanbul Medeniyet University
- Diseases
- Stroke
- NCT number
- NCT07538076
What you commit to
- Study type: Observational
- Planned participants: 105
- From 15 Apr 2026 to the primary completion date, 15 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of neurological or severe psychiatric disease before stroke that could significantly affect cognitive function or attention, such as brain tumor, traumatic brain injury, vasculitis, multiple sclerosis, or schizophrenia
- Severe upper extremity motor impairment or apraxia preventing interaction with the tablet or stylus pen
Other
- Severe visual field defect not attributable to visuospatial neglect, such as isolated homonymous hemianopia
- Inability to understand test instructions, cooperate with the assessment, or complete the evaluation process
Who the study is looking for
- Age 18 to 80 years
- First-ever ischemic or hemorrhagic stroke
- Hemiplegia secondary to stroke
- Stroke in the subacute or chronic phase, defined as 1 to 24 months after stroke onset
- Ability to provide written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.